Vera Therapeutics Files 8-K on Financials

Ticker: VERA · Form: 8-K · Filed: May 6, 2025 · CIK: 1831828

Vera Therapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyVera Therapeutics, INC. (VERA)
Form Type8-K
Filed DateMay 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, sec-filing

TL;DR

Vera Therapeutics dropped an 8-K on May 6th, check it for financial updates.

AI Summary

Vera Therapeutics, Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.

Why It Matters

This filing indicates Vera Therapeutics is providing updates on its financial status and operational results to the SEC, which is crucial for investors to assess the company's performance.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for reporting financial results and does not contain inherently risky information.

Key Players & Entities

FAQ

What specific financial results are being reported in this 8-K?

The provided text states the 8-K is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific figures within this excerpt.

When was the earliest event reported in this filing?

The earliest event reported was on May 6, 2025.

What is Vera Therapeutics, Inc.'s principal executive office address?

The principal executive offices are located at 2000 Sierra Point Parkway, Suite 1200, Brisbane, California, 94005.

What is the registrant's telephone number?

The registrant's telephone number is (650) 770-0077.

What is the SIC code for Vera Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code for Vera Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Vera Therapeutics, Inc. (VERA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing